Conclusion Of Non-Exclusive Discount Agreements In Accordance With §§ 130A Paragraph 8/130C Paragraph 1 Sgb V For Drugs With The Active Ingredients Tamsulosin And Dutasteride (G04Ca52) As Part Of A So-Called Open House Model.

AOK Rhineland-Palatinate Saarland - The health insurance company Germany has Released a tender for Conclusion Of Non-Exclusive Discount Agreements In Accordance With §§ 130A Paragraph 8/130C Paragraph 1 Sgb V For Drugs With The Active Ingredients Tamsulosin And Dutasteride (G04Ca52) As Part Of A So-Called Open House Model. in Pharmaceuticals. The tender was released on Apr 19, 2023.

Country - Germany

Summary - Conclusion Of Non-Exclusive Discount Agreements In Accordance With §§ 130A Paragraph 8/130C Paragraph 1 Sgb V For Drugs With The Active Ingredients Tamsulosin And Dutasteride (G04Ca52) As Part Of A So-Called Open House Model.

Deadline - Mar 31, 2025

GT reference number - 65010740

Product classification - Pharmaceutical products